Dual-Use Export Landscape Post-BIS Rule Changes
The October 2022 and 2023 BIS rules rewrote the technology export map. FDPR jurisdiction now reaches non-US products. PE portfolios with China tech exposure may already be non-compliant.
Executive Summary
Key assessment
The Bureau of Industry and Security (BIS) advanced computing and semiconductor rules enacted between October 2022 and November 2023 — and progressively tightened through 2025 — represent the most significant restructuring of US dual-use export controls since the Cold War. For private equity investors with Chinese technology portfolio companies, the practical consequences are severe: equipment already installed in PRC fabs may now constitute a continuing export control violation; portfolio companies supplying to Chinese AI or semiconductor firms may have acquired Entity List adjacency without realising it; and the Foreign Direct Product Rule (FDPR) extends US jurisdiction to products that contain no US components but were manufactured using US technology. This brief maps the current regulatory landscape, identifies the highest-risk deal structures, and provides a compliance assessment framework PE investors can apply before the next investment committee cycle.
Three findings shape this assessment. First, the BIS rule architecture is intentionally extraterritorial — it reaches non-US companies, non-US products, and non-US transactions through the FDPR and the de minimis rules. A European or Singaporean-registered fund investing in a Chinese technology company is not insulated from BIS jurisdiction if the underlying technology has US-origin content or was produced using US-controlled equipment. Second, the pace of rule changes has outrun most PE compliance programmes — the October 2023 update alone introduced new ECCN classifications, lowered TOPS thresholds, and extended HBM memory controls in ways that retroactively implicated equipment already deployed in China. Third, Entity List exposure is increasingly contagious: a portfolio company that supplies to, sources from, or shares personnel with a listed entity may itself face informal BIS scrutiny even before formal listing action.
The dual-use export control landscape is not a regulatory inconvenience. For PE investors with China technology exposure, it is a material valuation risk, a fiduciary disclosure obligation, and in the most serious cases, a criminal liability exposure for fund managers and portfolio company executives.
Issue #2 is available now in full to paid subscribers. Subscribe